Brain

1. FREEMAN SA, Liblau RS
   A novel TARGET for anti-CD20 antibody therapy in multiple sclerosis.
   Brain. 2026 Oct 17:awag360. doi: 10.1093.
   

   >> Share

   
   

   
   Curr Opin Immunol

2. ZIMMERMANN DM, Diamantino D, Andrade SO, Julio PR, et al
   The gastrointestinal pathway leading to autoimmune diseases.
   Curr Opin Immunol. 2026;103:102856.
   

   >> Share

   
   

   
   Diabet Med

3. TULLY AS, Binkowski SK, Nevin BR, Penno MAS, et al
   Understanding parents' perspectives of repeated blinded continuous glucose monitoring in children with early-stage type 1 diabetes and an affected first-degree relative.
   Diabet Med. 2026 Jul 14:e70424. doi: 10.1111/dme.70424.
   

   >> Share

   
   
4. WAITE MA, Kozlowska O, Martin C, Krezalek M, et al
   Piloting an immersive virtual reality 3D self-management education experience for adults with type 1 and type 2 diabetes mellitus: A qualitative study.
   Diabet Med. 2026 Jul 8:e70383. doi: 10.1111/dme.70383.
   

   >> Share

   
   
5. ZAREMBA N, Harrison A, Brown J, Pillay D, et al
   Experiences of receiving and delivering a novel complex intervention for type 1 diabetes and disordered eating: Process evaluation of the Safe management of people with Type 1 diabetes and EAting Disorders studY (STEADY).
   Diabet Med. 2026 Jun 11:e70377. doi: 10.1111/dme.70377.
   

   >> Share

   
   
6. HIRTLE J, Goraya N, Dunlop A, Booth J, et al
   A qualitative enquiry into the lived experiences of women with type 1 diabetes using closed-loop insulin delivery in pregnancy in the CIRCUIT trial.
   Diabet Med. 2026 Jun 11:e70388. doi: 10.1111/dme.70388.
   

   >> Share

   
   
7. ABILD CB, Knudsen JH, Schodt M, Gribsholt SB, et al
   Implementing Diabetes Eating Problem Survey - Revised in pediatric type 1 diabetes care: Clinician reflections on systematic screening and multidisciplinary management.
   Diabet Med. 2026 Apr 26:e70333. doi: 10.1111/dme.70333.
   

   >> Share

   
   

   
   Intern Med

8. OKAYA S, Ito H, Shiba T, Kurihara Y, et al
   Severe Transfusion-refractory Cytopenia Mimicking Bone Marrow Failure in a Patient Living with HIV after Antiretroviral Therapy Interruption.
   Intern Med. 2026;65:2773-2777.
   

   >> Share

   
   
9. MIYANO R, Yoshida Y, Fujita K, Hayashi Y, et al
   Embolic Ischemic Stroke Associated with Maintenance Intravenous Immunoglobulin Therapy.
   Intern Med. 2026;65:2758-2762.
   

   >> Share

   
   

   
   J Autoimmun

10. CARNEIRO P, Vicente MM, Alves I, Azevedo CM, et al
    Treg-associated oligomannose N-glycans trigger immune dysregulation in myasthenia gravis.
    J Autoimmun. 2026;165:103643.
    

    >> Share

    
    

    
    J Clin Endocrinol Metab

11. REGURAM R, Shah R, Vora T, Arsene C, et al
    Insulin Pump Use and Hospital Outcomes in Adults With Type 1 Diabetes: A 2022 Nationwide Readmissions Database Analysis.
    J Clin Endocrinol Metab. 2026 Jul 30:dgag307. doi: 10.1210.
    

    >> Share

    
    
12. WEBB T, Pechacek J, Lionakis MS
    Approach to the patient with APS-1/APECED.
    J Clin Endocrinol Metab. 2026;111:3277-3285.
    

    >> Share

    
    
13. MASUDA T, Katakami N, Taya N, Miyashita K, et al
    Classification of glucose profile in Japanese patients with type 1 diabetes and its association with complications.
    J Clin Endocrinol Metab. 2026 Jun 8:dgag224. doi: 10.1210.
    

    >> Share

    
    
14. SEAQUIST ER, Park YW, Kumar A, Alvear A, et al
    Impact of Recurrent Hypoglycemia on Brain Glucose Transport Kinetics in Type 1 Diabetes.
    J Clin Endocrinol Metab. 2026 May 13:dgag205. doi: 10.1210.
    

    >> Share

    
    

    
    J Immunol

15. TURNER TJ, Peterson SR, Alt LE, Aguilar Meza LS, et al
    TNFalpha promotes brain-predominant EAE independent of IFNgamma and IL-17A in HLA-DR3 transgenic mice.
    J Immunol. 2026;215:vkag268.
    

    >> Share

    
    

    
    J Nephrol

16. RATH A, Nigam JS, Pradeep I, Prasad P, et al
    Prognostic utility of Oxford MEST-C classification for allograft failure in transplant IgA nephropathy: A systematic review and meta-analysis.
    J Nephrol. 2026 Oct 14:aajag258. doi: 10.1093.
    

    >> Share

    
    

    
    J Neuroimmunol

17. GOMEZ-SALAZAR N, Ortiz-Salas PA, Jimenez-Tocasuche CA, Granados-Patino LA, et al
    Co-occurrence of myasthenia gravis and neuromyelitis optica spectrum disorder: A case series and literature review.
    J Neuroimmunol. 2026;422:579111.
    

    >> Share

    
    
18. GRUND E, Cross AH, Chahin S
    Multiple sclerosis: Advances in diagnosis, biomarkers, and disease management.
    J Neuroimmunol. 2026;422:579106.
    

    >> Share

    
    

    
    J Neurol

19. D'ORSO S, Picozza M, Guerrera G, Verdiani A, et al
    Antiviral and inflammatory immune signatures in anti-CD20-treated multiple sclerosis: a cross-sectional study.
    J Neurol. 2026;273:664.
    

    >> Share

    
    
20. TORTORELLA C, Cruciani A, Patti F, Capobianco M, et al
    Clinical phenotype and treatment response in AQP4-IgG-positive NMOSD and MOGAD: insights from the Italian I-MS&RD registry.
    J Neurol. 2026;273:665.
    

    >> Share

    
    

    
    J Rheumatol

21. JAMMAL C, Newton DW, Chen C, Mammen AL, et al
    A Case of Concurrent Antiacetylcholine Receptor-Positive Myasthenia Gravis and Anti-HMGCR-Positive Myositis Following Statin Exposure.
    J Rheumatol. 2026 Oct 15:jrheum.2025-0711. doi: 10.3899/jrheum.2025-0711.
    

    >> Share

    
    
22. GHEBRIAL M, Papasotiriou C, Kadhim MH, Peschken CA, et al
    Jaw Claudication Progressing to Scalp and Tongue Necrosis in Giant Cell Arteritis.
    J Rheumatol. 2026 Oct 15:jrheum.2026-0614. doi: 10.3899/jrheum.2026-0614.
    

    >> Share

    
    
23. FAIRLEY JL, Ross L, Paratz E, McKelvie P, et al
    The spectrum of cardiovascular disease in systemic lupus erythematosus and rheumatoid arthritis: a nationwide case-control postmortem study.
    J Rheumatol. 2026 Oct 15:jrheum.2026-0337. doi: 10.3899/jrheum.2026-0337.
    

    >> Share

    
    
24. ZHU L, Vinet E, Mendel A, Pineau CA, et al
    Patterns of NT-proBNP in Systemic Lupus Erythematosus.
    J Rheumatol. 2026 Oct 15:jrheum.2026-0384. doi: 10.3899/jrheum.2026-0384.
    

    >> Share

    
    

    
    Lancet Neurol

25. PATIL A, Vilaseca A, Dubey D
    From syndrome to antibody-defined autoimmune encephalitides.
    Lancet Neurol. 2026;25:971-973.
    

    >> Share

    
    
26. DALMAU J, Guasp M, Munoz-Lopetegi A, Spatola M, et al
    Antibody-mediated encephalitides: distinct diseases with transdisciplinary implications.
    Lancet Neurol. 2026;25:1039-1052.
    

    >> Share

    
    

    
    Mult Scler

27. BUIJZE MSJ, Molenaar S, Verkerk R, Quist MA, et al
    Frequent early cognitive impairment in both pediatric MS and MOGAD.
    Mult Scler. 2026;32:1168-1181.
    

    >> Share

    
    
28. MALLADI AR, Abbasi Kasbi N, Cohen JA, Stuve O, et al
    Induced pluripotent stem cell treatment for microglia replacement in progressive MS.
    Mult Scler. 2026;32:1129-1138.
    

    >> Share

    
    
29. TACCHINI M, Gamberini G, Dini M, Rossi C, et al
    Event-related potentials and behavioural correlates of cognitive functions in MS: An EEG study during symbol digit modalities test.
    Mult Scler. 2026;32:1182-1192.
    

    >> Share

    
    
30. IAFFALDANO P, D'Amico S, Lucisano G, Copetti M, et al
    Validation of generative artificial intelligence techniques for synthetic data generation in multiple sclerosis research: A comparison with real-world evidence from the Italian multiple sclerosis registry.
    Mult Scler. 2026 Oct 14:13524585261492525. doi: 10.1177/13524585261492525.
    

    >> Share

    
    
31. WESSELS MHJ, de Jong DJ, Barrantes-Cepas M, Jelgerhuis JR, et al
    Survivor bias and disease progression in observational cohorts in multiple sclerosis.
    Mult Scler. 2026 Oct 14:13524585261490350. doi: 10.1177/13524585261490350.
    

    >> Share

    
    
32. ZBRZESKI C, Schorr EM, Polineni SP, Brandstadter R, et al
    How well do junior neurology residents recognize multiple sclerosis? Analysis of the "Close the Loop" resident clinical acumen project.
    Mult Scler. 2026 Oct 12:13524585261492141. doi: 10.1177/13524585261492141.
    

    >> Share

    
    

    
    N Engl J Med

33. FURIE RA, Vital EM, Meier O
    Obinutuzumab in Active Systemic Lupus Erythematosus. Reply.
    N Engl J Med. 2026;395:1562.
    

    >> Share

    
    
34. PAMUK ON
    Obinutuzumab in Active Systemic Lupus Erythematosus.
    N Engl J Med. 2026;395:1562.
    

    >> Share

    
    

    
    Neurology

35. REYES-LEIVA D, Carbayo A, Vesperinas A, Caballero-Martinez F, et al
    Disease Control in Generalized Myasthenia Gravis: Consensus Definition, Evolution, and Patient Characterization.
    Neurology. 2026;107:e218557.
    

    >> Share

    
    

    
    PLoS One

36. NOVAK DJ, Grant M, Tice AM, Joy V, et al
    Identifying diagnostic testing gaps for antiphospholipid syndrome within a single healthcare system.
    PLoS One. 2026;21:e0359712.
    

    >> Share

    
    
37. BURBELO PD, Nee R, Huapaya JA, Plasse R, et al
    Predictive autoantibodies before the diagnosis of type I diabetes in adults.
    PLoS One. 2026;21:e0352531.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

38. LONG J, Huang J, Arai M, Nakamura Y, et al
    Autoimmunity induced by epigenome alteration affecting thymic Treg cell development.
    Proc Natl Acad Sci U S A. 2026;123:e2626262123.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share